30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: ConMed

Orthopaedic surgery product sales $101.8MM, -1%

  • Sports Medicine -3% (Sports Biologics +4%)
  • Powered Surgical -1%


  • Sports Med affected by foreign currency effects, government-imposed limits on procedures/spending in Europe (especially the U.K.), discontinued line of craniofacial devices (posted <$1MM in 2Q12, none in 2Q13)
  • Lithium ion battery, launched at AAOS, performing extremely well; can take market share in Europe
  • Note: Surgical visualization products previously included under Arthroscopy category are broken out separately, as video systems can be used in both general and orthopaedic surgery